Is Myeloma Research Examining Sequencing of CAR T and Bispecifics?
https://vimeo.com/930138615 Is the sequencing of CAR T-cell therapy and bispecific antibodies being examined in myeloma studies? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses what’s known about…
What Myeloma Patient Monitoring Occurs After Induction Therapy?
https://vimeo.com/930138670 What is involved in myeloma patient monitoring following induction therapy? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses some common treatment and monitoring scenarios that he…
Targeting of Myeloma Disease Progression and Bispecific Antibody Advantages
https://vimeo.com/930138395 How can myeloma progression and bispecific antibodies be used for myeloma care? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses how disease progression and genomic features…
What Are the Latest Artificial Intelligence Advancements for Myeloma?
https://vimeo.com/930138514 What artificial intelligence advancements have emerged for myeloma? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses the IRMMa prediction model for myeloma care, factors that go…
What Are the Benefits of Myeloma Consults and Second Opinions?
https://vimeo.com/930138742 What can myeloma consults and second opinions bring to patients? Expert Dr. Ola Landgren from University of Miami Sylvester Comprehensive Cancer Center discusses the benefits of consults, second opinions, and myeloma…
Myeloma Patient Expert Q&A: Dr. Ola Landgren
https://vimeo.com/929981922 START HERE bridges the gap between expert and patient voices, empowering myeloma patients to feel comfortable asking precise questions of their healthcare team. In this webinar, Dr. Ola Landgren…
Myeloma Patient Expert Q&A: Dr. Ola Landgren Resource Guide en español
Descargar Guía Descargar Guía See More from START HERE Myeloma
Myeloma Patient Expert Q&A: Dr. Ola Landgren Resource Guide
Download Resource Guide Download Resource Guide See More from START HERE Myeloma
How is Treatment Fitness Determined in Multiple Myeloma?
https://vimeo.com/922792585 How is treatment suitability assessed in myeloma care? Dr. Sikander Ailawadhi, an expert from Mayo Clinic, elaborates on the factors taken into account when determining the appropriateness of treatment for…
Navigating Myeloma CAR T-Cell Relapse: Patient Next Steps
https://vimeo.com/922787260?fl=pl&fe=sh What are next steps for myeloma CAR T-cell patients who experience relapse? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains options for relapsed myeloma patients and shares patient advice. Download Guide…
What Factors Shape Myeloma Treatment Options After Relapse?
What myeloma treatment options are there for patients who relapse? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains patient factors that must be considered in treatment options and how treatment options may…
What Are Guidelines for Rising Myeloma Marker Levels?
https://vimeo.com/922786088 What are multiple myeloma guidelines for marker levels? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses marker levels that are checked and levels that could be concerning for disease progression. Download…